ImportRefusal LogoImportRefusal

JAMP Pharma Corporation

⚠️ Moderate Risk

FEI: 3001883242 • Chilliwack, British Columbia • CANADA

FEI

FEI Number

3001883242

📍

Location

Chilliwack, British Columbia

🇨🇦

Country

CANADA
🏢

Address

8065 Aitken Rd, , Chilliwack, British Columbia, Canada

Moderate Risk

FDA Import Risk Assessment

32.3
LowModerateHighCritical

This firm has a moderate history of FDA import refusals. Some attention may be warranted.

Statistics

6
Total Refusals
8
Unique Violations
8/2/2004
Latest Refusal
3/11/2002
Earliest Refusal

Score Breakdown

Violation Severity
50.9×40%
Refusal Volume
31.3×30%
Recency
0.0×20%
Frequency
25.0×10%
How is this score calculated?

Proprietary Algorithm

  • 40% Violation Severity — AI-assessed (1-10)
  • 30% Refusal Volume — Logarithmic scale
  • 20% Recency — Decays over 5 years
  • 10% Frequency — Refusals per year

© ImportRefusal.com Original Analysis

Violation Summary

163×

DIRECTIONS

The article is subject to refusal of admission pursuant to section 801(a)(3) in that it is a device whose label appears to not bear adequate directions for use.

1182×

NOT LISTED

It appears the drug or device is not included in a list required by Section 510(j), or a notice or other information respecting it was not provided as required by section 510(j) or 510(k).

23001×

DIETARYLBL

The article is subject to refusal of admission pursuant to Section 801(a)(3) of the FD&C Act in that it is a dietary supplement that appears to be misbranded within the meaning of Section 403(s)(2)(B) of the FD&C Act in that the label or labeling fails to identify the product by using the term "dietary supplement", which term may be modified with the name of such an ingredient.

31401×

SBGINSENG

The article is subject to refusal of admission in that it appears to be Misbranded because it or its ingredients purport to be or are represented as Ginseng, but are not an herb or herbal ingredient derived from a plant classified within the genus Panax.

3331×

LACKS FIRM

The article is in package form and appears to not bear a label containing the name and place of business of the manufacturer, packer, or distributor.

3361×

INCONSPICU

Information required by the Act to be on the label or labeling does not appear to be conspicuous enough as to render it likely to be read and understood by the ordinary individual under customary conditions of purchase and use.

4881×

HEALTH C

The article is subject to refusal of admission pursuant to Section 801(a)(3) in that it appears to be misbranded in that the label or labeling bears an unauthorized nutrient content/health claim.

2231×

FALSE

The article is subject to refusal of admission pursuant to section 801(a)(3) in that it is a device whose labeling appears to be false or misleading.

Refusal History

DateProductViolationsDivision
8/2/2004
54FEL12GINSENG (HERBAL & BOTANICALS, NOT TEAS)
3140SBGINSENG
Seattle District Office (SEA-DO)
5/30/2003
60LCL01ACETAMINOPHEN (ANALGESIC)
223FALSE
336INCONSPICU
Seattle District Office (SEA-DO)
3/24/2003
66VBL99MISCELLANEOUS PATENT MEDICINES, ETC.
118NOT LISTED
16DIRECTIONS
Seattle District Office (SEA-DO)
3/24/2003
66VBL99MISCELLANEOUS PATENT MEDICINES, ETC.
118NOT LISTED
16DIRECTIONS
Seattle District Office (SEA-DO)
3/24/2003
66VBL99MISCELLANEOUS PATENT MEDICINES, ETC.
16DIRECTIONS
333LACKS FIRM
Seattle District Office (SEA-DO)
3/11/2002
54FCH99HERBALS & BOTANICALS (NOT TEAS), N.E.C.
2300DIETARYLBL
488HEALTH C
Seattle District Office (SEA-DO)

Frequently Asked Questions

What is JAMP Pharma Corporation's FDA import refusal history?

JAMP Pharma Corporation (FEI: 3001883242) has 6 FDA import refusal record(s) in our database, spanning from 3/11/2002 to 8/2/2004.

What is an FEI number?

FEI stands for Firm Establishment Identifier. It's a unique number assigned by the FDA to identify establishments that manufacture, process, pack, or hold food, drugs, medical devices, or other FDA-regulated products. JAMP Pharma Corporation's FEI number is 3001883242.

What types of violations has JAMP Pharma Corporation received?

JAMP Pharma Corporation has been cited for 8 different violation type(s). Common FDA violations include adulteration (unsafe or unsanitary products), misbranding (incorrect or misleading labels), and regulatory non-compliance.

Where does this information about JAMP Pharma Corporation come from?

All FDA import refusal data for JAMP Pharma Corporation is sourced from the official FDA Data Dashboard (datadashboard.fda.gov), a public government database maintained by the U.S. Food and Drug Administration.

Data sourced from the FDA Data Dashboard, a public database maintained by the U.S. Food and Drug Administration.